MedLife exceeds half a billion euros in turnover, up 25 percent in 2024

MedLife, the largest private healthcare network in Romania, announces its preliminary financial results for 2024, highlighting a significant increase in Pro forma consolidated turnover, which reached over RON 2.7 billion (EUR 555 million), up 25 percent compared to 2023. Thus, the Group becomes the first Romanian company in the private healthcare sector to exceed half a billion euros in turnover in 2024.

Also, Pro-forma EBITDA reached RON 412 million in 2024 compared to RON 317 million in the previous year, which highlights the Group’s stability in terms of profitability growth in 2024. At the same time, the Pro-forma net profit obtained by the Group in 2024 amounted to RON 33 million.

”Despite a much slower economic growth of only 0.9 percent, the 2024 results attest that MedLife has managed to maintain its financial and operational business performance. Thanks to these results, which give us reasons for optimism, we will continue our development projects. In this regard, we have proposed to supplement the syndicated loan with 50 million euros and we hope to have it approved by shareholders in March. Although we expect a complicated year, marked by many geopolitical challenges and the need for significant fiscal adjustments in Romania, we have taken the necessary strategic measures to perform even in a period marked by uncertainties. Moreover, in recent years, in addition to diagnostic and prophylaxis platforms, we have also developed an integrated oncology platform and top hospital services, thus offering an important range of medical services that cannot be postponed to the next economic cycle. Moreover, we will soon launch, for the first time, several medical health monitoring services along with wellness, nutrition and stress management services. These services offered to companies can overcome the lack of salary increases in difficult economic times, while maintaining the benefit packages so necessary for team motivation and a performing and healthy climate”, declared Mihai Marcu, President and CEO of MedLife Group.

Most of the MedLife Group’s business lines recorded a good performance compared to 2023. Thus, the largest increases were recorded by hospitals (38 percent), laboratories (28 percent), followed by clinics (23 percent) and, equally, by pharmacies and the corporate division (14 percent).

MedLife expanded in 2024 both through acquisitions and organically. The acquisitions include Antares Clinic, one of the most important private healthcare providers in Moldova, Euromedica Group Baia Mare (Euromedic Hospital and Euromedic Administrator) and Routine Med Group from Tulcea.

As for organic growth, MedLife inaugurated three hospitals in Bucharest, Craiova and Timisoara, becoming one the largest providers of hospital services both in the capital and nationally.

In 2025, the Group’s first move will be to consolidate in the Corporate segment, where MedLife wants to meet employers with new products, that will combine medical prevention with fitness. In parallel with this approach aimed at the corporate area, the Group will continue its organic development, with several projects started last year planned to be put into operation, such as the expansion of the number of hyperclinics by adding one in the central-southern part of Romania, the inauguration of a new radiotherapy center in the north-east of the country, as well as the expansion with new units dedicated to mental health and fitness in Bucharest and in the country.